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MTHFR C677T polymorphism
and skin color: The white
man’s blackness
To the Editor: The C677T polymorphism of methyl-
enetetrahydrofolate reductase (MTHFR) gene is linked
to higher homocysteine levels and risk for myocardial in-
farction and stroke. MTHFR catalyzes the reaction, pro-
ducing methyltetrahydrofolate, the active form of folic
acid, in the remethylation of homocysteine to methio-
nine. Hyperhomocysteinemia is a known cardiovascular
risk factor, with effects on gene allelic expression in ure-
mic patients [1, 2].
The frequency of the C677T polymorphism is, in its ho-
mozygous TT form, about 20% and more in whites, and
1% or less in blacks from Africa or the United States
[3]. It has been proposed that a selective advantage in
possessing this variant lies in the capability to conserve
folates for DNA production during times of relative fo-
late deficiency. It is not clear why black people shouldn’t
possess this selective advantage.
A dark skin color has been recently envisioned as a
means through which man protects himself from folate
destruction because folates are highly susceptible to ul-
traviolet A (UVA) ray degradation. Skin color represents
a delicate balance between the need to produce enough
vitamin D and folate conservation, in particular when fo-
lates are scarce [4].
We put forward the hypothesis that in black people,
skin color allows for some vitamin D production, while it
protects from folate degradation, and no reason why the
MTHFR variant should have been favored. White people
instead have evolved in a population of individuals where
the MTHFR TT genotype is favored for folate conserva-
tion. Little sun exposure allows for limited folate degra-
dation, and in times of folate deficiency these individuals
would produce enough folates for DNA synthesis. There-
fore, the MTHFR thermolabile variant would represent
“the white man’s blackness.”
ALESSANDRA F. PERNA, DIEGO INGROSSO,
and NATALE G. DE SANTO
Naples, Italy
Correspondence to Alessandra F. Perna, Division of Nephrol-
ogy/Department of Pediatrics, Second University of Naples, Via Pansini
5, Ed. 17, Naples, Italy 80131.
E-mail: alessandra.perna@unina2.it
REFERENCES
1. PERNA AF, INGROSSO D, LOMBARDI C, et al: Possible mechanisms of
homocysteine toxicity. Kidney Int 84:S137–S140, 2002
2. INGROSSO D, CIMMINO A, PERNA AF, et al: Folate treatment and un-
balanced methylation and changes of allelic expression induced by
hyperhomocysteinaemia in patients with uremia. Lancet 361:1693–
1699, 2003
3. BOTTO LD, YANG Q: 5,10-Methylenetetrahydrofolate reductase
gene variants and congenital anomalies: A HuGE review. Am J
Epidemiol 151:862–877, 2000
4. JABLONSKI NG, CHAPLIN G: The evolution of human skin coloration.
J Hum Evol 39:57–106, 2000
Mitochondrial causes of renal
insufficiency and hearing loss
To the Editor: A recent paper in Kidney International
by Izzedine et al [1] provided an excellent review of ear
and kidney syndromes. We would like to call attention
to another syndrome that can be associated with hear-
ing loss and renal disease. Mutations in the mitochon-
drial gene MTTL1, which encodes tRNA Leu(URR), can
also cause renal dysfunction and hearing loss. In the most
severe form, mutations in this gene cause MELAS syn-
drome (Mitochondrial myopathy, Encephalopathy, Lac-
tic Acidosis, and Stroke), which is a multisystem disorder
that can present with cerebral vascular accidents, seizures,
hearing loss, cardiomyopathy, diabetes, and nephropathy.
Mutation analysis of MTTL1 in MELAS patients reveals
that 80% have the mutation A3243G, 7.5% have T3271C,
and 7.5% to 10% have A3253G [2].
We have evaluated three unrelated patients with the
MTTL1 A3243G mutation and features of MELAS syn-
drome: a 48-year-old man with a creatinine of 2.0 g/dL
who presented with cardiomyopathy, diabetes, and hear-
ing loss; a 22-year-old woman with an iothalamate clear-
ance of 67 mL/min who presented with cardiomyopathy,
history of a thalamic stroke, an elevated blood lactate, and
progressive hearing loss; and a 28-year-old woman with
an iothalamate clearance of 29 mL/min who presented
with hypertrophic cardiomyopathy, history of a stroke,
